Yahoo Web Search

Search results

1. • 

     Exploring Three Growth Companies With High Insider Ownership On Euronext Paris

     Simply Wall St. via Yahoo Finance· 4 days ago

     As global markets navigate through varying performances, with the pan-European STOXX Europe 600...

2. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 3 days ago

     NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If you invested in Cerevel Therapeutics you are encouraged

3. • 

     Assertio names Brendan O'Grady as new CEO By Investing.com

     Investing.com· 5 days ago

     Assertio Holdings, Inc. (NASDAQ:ASRT), a commercial pharmaceutical company, announced today the...

4. • 

     Euronext Paris Growth Companies With High Insider Ownership And 68% Earnings Growth

     Simply Wall St. via Yahoo Finance· 5 days ago

     Amidst a backdrop of fluctuating European markets, with France's CAC 40 Index experiencing a modest...

5. • Novartis sues Maryland over law prohibiting restrictions on 340B drugs

     Becker’s Hospital Review· 4 days ago

     "Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."

6. • 2023 Highlights in Canadian Life Sciences IP and Regulatory Law | JD Supra

     JD Supra· 4 days ago

     Allergan Inc v Juno Pharmaceuticals Corp (bimatoprost, LUMIGAN RC) – The FC granted Allergan’s s. 6(1) action under the Regulations; infringement was conceded, formulation ...

7. • 

     Euronext Paris Growth Leaders With High Insider Stakes May 2024

     Simply Wall St. via Yahoo Finance· 7 days ago

     As of May 2024, the French market, like many global counterparts, has shown mixed performance with...

8. • Generic-Drug Disputes Fuel New Jersey's Surge in Patent Litigation\t\t | New Jersey Law Journal

     Law.com· 4 days ago

     New Jersey’s federal courts are in the midst of a surge in patent litigation, driven by pharmaceutical companies’ claims of infringement against generic-drug producers. Plaintiffs ...

9. • JD Supra: EU and UK Consider First Stand-Alone Disparagement Cases

     JD Supra· 5 days ago

     The development of case law on disparagement has, to date, been driven mainly by the French competition authority, or has been addressed under consumer protection or other national laws. The ...

10. • 

      Some prescription drugs are hard to fill. A pair of bills could make it easier.

      Rhode Island Current via Yahoo News· 4 days ago

      Stimulants can make life calmer and easier for people with ADHD. But filling these prescriptions is...